We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Low Zinc May Indicate Potential Breast-Feeding Problems

By LabMedica International staff writers
Posted on 27 Dec 2015
A new study provides an important step toward identifying breast-fed infants at risk for severe zinc deficiency. More...
Identifying mothers with abnormally low levels of zinc in breast milk may enable to more quickly determine those more likely to have trouble breast-feeding.

The protein ZnT2 transports zinc in specific tissues, including the mammary glands, where zinc is necessary for growth of mammary glands and function of mammary epithelial cells and secretion pathways. In previous studies, Shannon L. Kelleher, associate professor at Penn State University’s College of Medicine (Hershey, PA, USA) and colleagues found that ZnT2 is critical for secreting zinc into breast milk and women who have ZnT2 mutations have substantially lower milk zinc levels, leading to severe zinc deficiency in exclusively breast-fed infants. Also, ZnT2 deletion in mice altered milk composition and profoundly impaired the ability of mice to successfully nurse their offspring.

Now the researchers have found that ZnT2 genetic variation resulting in either loss or gain of function may be common and in some cases is associated with indicators of poor breast function. Of 54 breast-feeding women, 36% had at least one non-synonymous single nucleotide polymorphism (SNP) in ZnT2 and the genetic variation was associated with abnormal levels of zinc in their breast milk. 12 previously unknown variants of ZnT2 were identified in the participants, and 5 of these variants were statistically associated with abnormal zinc levels in breast milk. "We had no idea that genetic variation in ZnT2 would be so common," said Prof. Kelleher.

Among the 36% of breast-feeding women found to have at least one genetic variant in ZnT2, all had an abnormally low or high level of zinc in breast milk. However, abnormal zinc levels did not automatically imply a problem with ZnT2, indicating that other factors remain to be identified.

The participants were sorted into 4 groups according to breast milk zinc levels. In the group with the lowest zinc levels, researchers identified ZnT2 variants in 79% of the women; in the group with the highest levels, 29% had ZnT2 variants. Importantly, among the subjects with normal milk zinc levels, no variants in ZnT2 were detected.

The researchers also examined the milk for ratio of sodium to potassium (Na/K) as a known indicator of breast dysfunction, including infection and inflammation of the breast. 12% of women had the most common ZnT2 variant, T288S, and had a significantly higher Na/K ratio compared with women with no variation in ZnT2. Another 9% of women with a different, less common ZnT2 variant, D103E, had a higher Na/K ratio than women with no ZnT2 variation, although this was not significant due to the low number of women in the study with this variant.

Together these observations point to ZnT2 variation as a modifier of breast function and zinc levels in breast milk as a potential indicator of deficient lactation. Further research is needed to better understand how genetic variation affects milk zinc levels and breast function.

The study, by Alam S et al., was published in the December 2015 issue of the Journal of Mammary Gland Biology and Neoplasia.

Related Links:

Penn State Hershey College of Medicine 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.